Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”

HB 1364, a bill some radiologists pushed back against, is headed to the Governor’s desk to be finalized. It is set to take effect on Oct. 1. 

"Topped-out" measures may not actually reflect universally high performance, a new analysis of CMS data shows. 

The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.

Radiopharma firm Telix hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer. 

In October, Harrison.ai submitted a citizen petition seeking greater flexibility in the 520(k) clearance process for certain computer-aided detection devices.

ACR and numerous others recently wrote letters to both the U.S. House and Senate, urging them to support the Lorna Breen Mental Health Act. 

CMS officially announced the move on April 6, with it applying to the Wasteful and Inappropriate Service Reduction (WISeR) Model. 

The insurer (also known as Elevance) first launched its new “nonparticipating care providers” policy across 11 states beginning on Jan. 1, drawing widespread criticism. 

Ohio Senate Bill 324 would exempt NPs and PAs from certain licensure requirements, allowing them to supervise X-ray machine operators.